Market Size (2016)
2016
$4.66B
Vertical: HealthcareBase Year: 201811 Sections
Market Size (2016)
2016
$4.66B
Projected (2024)
2024
$19.60B
CAGR (2016–2024)
19.7%
19.7%Key Players
108+
This report covers Surgical Robots Market with forecasts from 2016 to 2024. 108 key companies are profiled.
The Surgical Robots Market market is projected to grow at a CAGR of 19.7% from 2016 to 2024.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansRobotic-assisted surgery is a type of minimally invasive surgery that allows healthcare professionals to perform many complex procedures with more precision, flexibility, and control, which is possible with conventional techniques. It has also been used in specific traditional open surgical procedures. Surgical robots are the medical robots that perform the procedures through tiny incisions. The da Vinci System is the world’s most advanced surgical robot. It has miniaturized instruments that are attached on three separate robotic arms that permits the surgeon maximum range of motion and precision. In 2016, The da Vinci System performed approximately 563,000 procedures in the US, of which 44% were gynecological, 33% were general surgeries, and 19% were urological. Procedure count outside of the US was approximately 190,000.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2018
Historical Period
2016 – 2018
Forecast Period
2018 – 2024
Primary Interviews
150+
Historical data (2016–2018) and forecast period (2018–2024)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansBargaining Power of Suppliers
The industry impact of the supplier’s bargaining power is considered to have a medium-level impact. The bargaining power of the suppliers estimates how easy it is for the suppliers to influence the prices of surgical robots. Businesses must obtain the necessary resources that they need from the resource suppliers to carry out their activities. The price of the surgical robots is determined by the interaction between the suppliers and the end users.
The number of suppliers serving the surgical robots industry is comparatively higher than the number of firms operating in the sector, thereby advantaging the firms due to lower switching-cost. The suppliers-to-firm concentration ratio also favors the firms, while the competition among the suppliers is high due to the high value of the transaction. The factors favoring the suppliers are the high-quality and degree of differentiation of inputs required, which reduces the chances of substitutes.
Bargaining Power of Buyers
The bargaining power of the buyer is considered to have a low impact on the industry. The bargaining power of the buyers assesses how easy it is for the buyers to affect the price of surgical robots. The bargaining power of the buyer is low as surgical robots are generally customized as per the client requirements, which raises the switching costs. Customization also reduces the chances of substitution due to the greater risk of compatibility issues while the cost of procedural switching is high, and the threat of backward integration is low. The buyers to firm concentration ratio are medium, which restricts the power of the buyers. However, the latest trend of mergers between large healthcare providers, coupled with strategies such as demand pooling by multiple players, is increasing the power of the buyers.
Threat of New Entrants
Threat from a new entrant is considered to have a high impact on the industry. In Porter’s Five Forces Analysis, ‘Threat of New Entrants’ refers to the threat that new competitors pose to existing competitors in an industry. A profitable industry will attract more competitors looking to achieve profits. As the number of entrants increases, the profitability of the present players in the industry subsequently decreases.
The surgical robots industry has a high capital intensity, which raises the barrier for entry. The cost of production is also high and devising lower-cost manufacturing methods quickly, is difficult, especially for a new player. Proprietary technology remains the critical factor in raising the cost disadvantages independent of size. Thus, any new player cannot capture the market only by going for economies of scale, which due to the low volume of robotic surgery cannot be achieved easily. The distribution chain is another hurdle facing any new player which is dominated by the existing players. The number of distribution chains is low, and the development of newer distribution chain is very costly. Another source of entry barrier is the strong intellectual property laws and the worsening conditions of access to capital, especially venture capital. The access to venture capital has been on a negative trend since the economic recession and is also biased towards existing players with end-stage projects.
Strong brand identities and extreme differentiation of products impart high marketing costs on any newcomer. Switching costs are high as there are only a few dominant players to divest the existing facility in case of exit, which may lead to distress sale of the facility. However, the high profitability of surgical robots is an incentive for a new entrant, especially if he is armed with an innovative product.
Threat of Substitutes
Any threat from a substitute is considered to have a low impact on the industry. The threat from the substitutes arises when the customers or the buyers in the market can achieve the end-result using other means excluding the market we are concerned. Threat from substitute is low as the buyers switching costs are high. Substitution involves high training cost on the new systems, which also reduces the incentive for it. Also, many large hospitals and surgical robots manufacturers are in a partnership to reduce operating costs and to increase market exposure, which makes substitution a part of strategic partnerships.
Intensity of Rivalry
Degree of competition is considered to have a high impact on the industry. The Intensity of Competitive Rivalry evaluates the capability and the level of rivalry among competitors in the market. It also refers to the extent to which firms within an industry put pressure on one another and limit each other’s profit potential. Industries strive for a competitive advantage over their rivals, and the intensity or rivalry varies across industries. Rivalry among industry players can affect industry profits through downward pressure on prices, increased innovation, increased advertising, and increased service/product improvements, among others.
If the rivalry is fierce, the competitors might try to steal profit and market share from one another. This reduces profit potential for all firms within the industry. Factors that increase a certain level of competitive rivalry among existing firms include the analysis criteria such as many suppliers, price and quality wares, and the presence of application-specific players. Also, the high growth rate of industry enhances the competition among the players. Surgical robots have a high-profit margin compared to the low volume of production, which automatically creates intense competition as each new firm tries to cut the advantage of established competitors. However, increasing volumes of business may result in greater accommodation of players as the US surgical robots market is set to expand.
The secretive proprietary technologies also impart high rivalry and competition between the firms. The market players in these sectors have huge economic clout along with market channels. Thus, the dominance of a handful of large players provides an opportunity for intense competition and rivalry.
Market estimates by geography (2024)
InsightAmericas leads with $8.53B by 2024, while Asia Pacific is projected to grow fastest at a 21.1% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2016 | 2018 | 2024 | CAGR | SHARE |
|---|---|---|---|---|---|
| Europe | $1.50B | $3.16B | $6.25B | 19.5% | 32% |
| Asia Pacific | $912.85M | $2.02B | $4.22B | 21.1% | 22% |
| Middle East and Africa | $284.10M | $436.50M | $592.87M | 9.6% | 3% |
| Americas | $1.96B | $4.21B | $8.53B | 20.2% | 44% |
| Total | $4.66B | $9.83B | $19.60B | 19.7% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$19.60B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Instrument and Accessories | $8.12B | 19.7% | 78% |
| Services | $6.24B | 19.7% | 89% |
| Robotic Systems | $5.24B | 19.7% | 72% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Surgical Robots Market covering market dynamics, competitive landscape, and strategic outlook.
The Surgical Robots Market market is projected to reach $19.60B by 2024, growing at 19.7% CAGR. The Instrument and Accessories segment holds the largest share.
With the growing advancement in robotics, the researchers have developed a unique and technology-based revolutionary equipment which performs the activities with the minimum insertions. These surgical robots allow healthcare professionals to reach difficult anatomical positions with only a flick of controls. With the rising incidences of chronic conditions and increasing geriatric population base, the probability of surgical intervention increased multi-fold, which has accelerated the growth of the global surgical robots market.
The global surgical robots market is emerging due to the technological advancement in surgical robots. Additionally, rising preference for minimally invasive surgeries, increase in funding for surgical robot research, and rising adoption of advanced medical technologies and surgical robots, which is expected to boost the market growth.
However, the high cost of surgical robots and risks associated with the robotic-assisted surgeries are hampering the growth of the global surgical robots market.
There has been a consolidation of large healthcare players such as insurance companies and hospitals in the US to curtail the rising healthcare cost and to achieve the economies of scale. This consolidation also had a positive effect on their buying power, which is good news for surgical robots. Large healthcare is in the position to buy and maintain these surgical robots. These players can also reduce the mutual cost of installation and maintenance of robots, thereby increasing affordability and market penetration.
The cost is the major restraint of surgical robots, which may increase by USD 1500 to USD 3000 as compared to traditional surgery. Installation and operation of surgical robots require large operating space, which involves additional costs. This coupled with the cost of making the robots is unaffordable. For example, for robotic laparoscopic surgery, the cost of a single robot may be about USD 2 million with disposable attachments may cost anywhere from USD 3,000 to USD 6,000 more than traditional laparoscopic surgery. This high cost for surgical robots hampers the growth of the global surgical robots market.
Robotic surgery is very new, and surgical robots themselves are in an early stage of development. Although technology is improving much needs to be done, and more experience has to be gained. Technology improvements with high priority and need include haptics, processor speeds, and more sophisticated software. Another requirement is the development of self-learning systems.
Near-term growth will likely concentrate in modular bioreactor lines and closed-system media workflows that shorten validation cycles while preserving batch traceability.
Partnerships between CDMOs and instrumentation vendors should accelerate standard datasets for comparability across sites, improving forecasting models used in capacity planning.
Longer horizon, organoid and microphysiological adoption may reshape segment mix; teams that invest early in assay interoperability and cloud QC hooks are better positioned to capture upside without fragmenting their analytics stack.
Profiles of 108 companies operating in the Surgical Robots Market market, including revenue, employee count, and market positioning where available.
Showing 108 of 108 companies
Renishaw plc
Company Headquarters: Gloucestershire, UK Founded: 1973 Workforce: ~4,000 Company Working: Renishaw plc is one of the world’s leading engineering and scientific technology companies, which also specializes in precision measurement and healthcare. It supplies products for applications such as metrology, Raman spectroscopy, motion control, machine tool automation, calibration, co-ordinates measurement, CAD/CAM dentistry, additive manufacturing/3D printing, stereotactic neurosurgery, and molecular diagnostics.
Medtech SA
Company Headquarters: Montpellier, France Founded: 2002 Workforce: ~200 Company Working: Medtech SA (Medtech) designs, develops, and markets a new generation of robotic assistance for the express purpose of improved medical and surgical technique. The company’s robots contribute to safer and more stable implantation of both more effective and less invasive treatments. It developed ROSA, an innovative technological device devoted to brain surgery procedures. The company’s mission is to be instrumental in the use of minimally invasive surgical procedures for patient benefit and improved cost control.
Medrobotics Corporation
Company Headquarters: Massachusetts, US Founded: 2005 Workforce: ~200 Company Working: Medrobotics Corporation (Medrobotics) manufactures and markets the Flex Robotic System. This system is the world’s first endoluminal robotic platform with a steerable and shapeable robotic scope. The Flex Robotic System offers clinicians the unique ability to navigate complex anatomy with crystal clear 3D and HD visualization through a single entry point. Once the target disease is accessed, the Flex Robotic System provides a stable platform through which flexible articulating instruments are introduced providing consistent triangulation in hard-to-reach anatomical locations that might otherwise be inaccessible with traditional surgical instruments and difficult to treat with current endoscopic instruments.
Verb Surgical Inc
Company Headquarters: California, US Founded: 2015 Workforce: ~201-500 Company Working: Verb Surgical Inc (Verb Surgical) is a medical device company which manufactures robotic-assisted surgical products. Verb Surgical was founded by collaborating technology and expertise. It was funded by Verily (formerly Google Life Sciences) and Ethicon, a medical device company in the Johnson & Johnson family of companies. The company aims to develop a comprehensive surgical solutions platform which can incorporate leading-edge robotic capabilities and best-in-class medical device technology for operating room professionals.
Hansen Medical
Company Headquarters: California, US Founded: 2002 Workforce: ~201-500 Company Working: Hansen Medical is the subsidiary of Auris Surgical Robotics which develops robotic technology for medical application. Hansen Medical manufactures robotic solutions that help surgeons for their procedural and therapeutic use. The company provides a wide range of products, including intravascular robotics, endovascular robotics, and medical robotics. It offers two major robotic systems, Sensei robotic systems and the Magellan robotic system. It also produces Artisan control catheters which are used in electrophysiology procedures and Magellan robotic catheter that is used for peripheral vascular interventions, among others.
Mazor Robotics
Company Headquarters: Caesarea, Israel Founded: 2001 Workforce: ~200 Company Working: Mazor Robotics develops, manufactures, and markets robotic-based technology and products for supporting surgical procedures in the fields of orthopedics and neurosurgery. The company strives towards its mission to help heal patients by innovating spine and brain surgery with transformative guidance systems. It is elevating spine and brain surgery from typical freehand procedures to cutting-edge, effective, state-of-the-art procedures, which define the future of surgical technology.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Surgical Robots Market